Thymosin treatment of children with primary immunodeficiency disease.
D000293:Adolescent; D000361:Agammaglobulinemia / Q000188:drug therapy; D001260:Ataxia Telangiectasia / Q000188:drug therapy; D002051:Burkitt Lymphoma / Q000188:drug therapy; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000276:immunology; D008206:Lymphatic Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013577:Syndrome; D013601:T-Lymphocytes / Q000276:immunology; D013947:Thymosin / Q000627:therapeutic use*; D013950:Thymus Gland / Q000002:abnormalities; D013951:Thymus Hormones / Q000627:therapeutic use*
D013951:Thymus Hormones; D013947:Thymosin